Mitochondrial disorders causing neurodegeneration in childhood are genetically heterogeneous, and the underlying genetic etiology remains unknown in many affected individuals. We identified biallelic variants in PMPCB in individuals of four families including one family with two affected siblings with neurodegeneration and cerebellar atrophy. PMPCB encodes the catalytic subunit of the essential mitochondrial processing protease (MPP), which is required for maturation of the majority of mitochondrial precursor proteins. Mitochondria isolated from two fibroblast cell lines and induced pluripotent stem cells derived from one affected individual and differentiated neuroepithelial stem cells showed reduced PMPCB levels and accumulation of the processing intermediate of frataxin, a sensitive substrate for MPP dysfunction. Introduction of the identified PMPCB variants into the homologous S. cerevisiae Mas1 protein resulted in a severe growth and MPP processing defect leading to the accumulation of mitochondrial precursor proteins and early impairment of the biogenesis of iron-sulfur clusters, which are indispensable for a broad range of crucial cellular functions. Analysis of biopsy materials of an affected individual revealed changes and decreased activity in iron-sulfur cluster-containing respiratory chain complexes and dysfunction of mitochondrial and cytosolic Fe-S cluster-dependent enzymes. We conclude that biallelic mutations in PMPCB cause defects in MPP proteolytic activity leading to dysregulation of iron-sulfur cluster biogenesis and triggering a complex neurological phenotype of neurodegeneration in early childhood.
Introduction
Mitochondria are indispensable for cellular function as these organelles are involved in many critical cellular processes. Mutations in mitochondrial or nuclear genes can cause mitochondrial diseases comprising a heterogeneous group of conditions that represent a significant proportion of complex neurological disorders of childhood, particularly conditions with a neurodegenerative course. [1] [2] [3] The vast majority of mitochondrial genes are encoded in the nuclear genome requiring a well-orchestrated import of mitochondrial preproteins after their translation on cytosolic ribosomes into the organelle. [4] [5] [6] [7] Approximately 70% of preproteins carry N-terminal cleavable presequences that function as targeting signals for mitochondrial protein import. 8 Complex protein import machineries recognize the presequences and facilitate translocation of the precursors across the mitochondrial membranes. [4] [5] [6] 9, 10 The essential mitochondrial processing protease (MPP) located in the mitochondrial matrix is the key enzyme to remove these presequences to allow folding and functioning of the mature protein. MPP is highly conserved from yeast to human and consists of two subunits: the catalytic PMPCB subunit (Mas1 in yeast) and the non-catalytic PMPCA subunit (Mas2 in yeast). While PMPCB/Mas1 is a metalloprotease with a zinc-binding motif, PMPCA/Mas2 has been implicated in substrate recognition and binding.
and were suspected of having a mitochondrial disorder. Analysis of human induced pluripotent stem cells (hiPSCs) derived from one of the affected individuals and neuroepithelial stem cells (NESs) differentiated thereof, fibroblasts as well as functional studies in yeast bearing the affected individuals' variants in the homologous Mas1 protein demonstrate that the identified PMPCB variants severely impair mitochondrial presequence processing. Furthermore, the yeast model revealed significant defects in the mitochondrial biosynthesis of iron-sulfur clusters, which are indispensable for many cellular functions including mitochondrial bioenergetic processes, nuclear genome maintenance, and cytosolic protein translation. Analysis of biopsied material from an affected individual identified changes in the formation and decreased activity of respiratory chain complexes, which have several Fe-S clusters incorporated, and dysfunction of the iron-sulfur cluster containing aconitase enzyme localized in mitochondria and the cytosol. We identify disease-causing mutations in PMPCB as a new mechanism in mitochondrial disease triggering a Leigh-like phenotype with cerebellar atrophy in early childhood.
Subjects and Methods

Subject Evaluation
Informed consent for participation in this study was obtained from all parents in agreement with the Declaration of Helsinki. All studies were completed per protocol with local approval by institutional review boards (IRB). All families underwent detailed review of clinical data for study inclusion. Family A was evaluated at the Mitochondrial Clinic of Children's Hospital Colorado, Aurora, USA and consented on IRB-approved studies (COMIRB 07-0386 and 16-0146). Family B was evaluated at the Department of Genetics at Cook Children's Physician Network in Fort Worth, Texas, USA, and enrolled through a research protocol at the Children's Hospital of Philadelphia. Family C was evaluated at the Victorian Clinical Genetics Services, Murdoch Children's Research Institute, and the study was approved by the local institutional ethics committees at the Royal Children's Hospital, Melbourne, Australia, and Yokohama City University Faculty of Medicine, Yokohama, Japan. Family D was evaluated at the Department of Neuropediatrics, University of Kiel, Germany, in the setting of the EuroEPINOMICS project on Rare Epilepsy Syndromes (RES) and a Trilateral Project German-Israeli-Palestinian project by the German Research Foundation. The EuroEPINOMICS study and the Trilateral project (A 115/02, A 116/02) as well as the protocol for the generation of hiPSCs at the Zentrum für Integrative Psychiatrie at the University Hospital Schleswig-Holstein were approved by the local institutional review board of the University Kiel (A 145/11). The GeneMatcher tool was used to search and identify additional individuals with PMPCB variants as the suspected diagnosis. 16 
Genetic Analysis
Family A Trio-based whole-exome sequencing (WES) was performed by the Medical College of Wisconsin (Milwaukee, WI). Targeted enrichment used the Agilent All Exon Kit, v.4. Sequencing was performed on an Illumina HiSeq 2500 per manufacturer protocols. Reads were mapped to the reference human genome (GRCh37/hg19) using Burrows-Wheeler Aligner (BWA). 17 Variants were called using SAMtools 18 and further annotated using SeattleSeq. Filtering and test of inheritance model were done using Galaxy. 19 Variants were filtered against dbSNP build 137, 1000 Genomes (November 23, 2010 release version), Exome Variant Server (EVS, ESP6500SI-V2), and Exome Aggregation Consortium ExAC browser (v.0.3). Rare variants were identified with minor allele frequency less than 1% using dbSNP137. The sequence data from the family were then used to test for causal variants under different inheritance models. The PMPCB variants were verified by Sanger sequencing. Family B Trio-based WES was performed by a commercial laboratory (Ambry Genetics) as previously described. 20, 21 In brief, samples were prepared with the IDT xGen Exome Research Panel V1.0 (IDT) and sequenced using paired-end, 100-cycle chemistry on the Illumina HiSeq 2500 platform (Illumina). Sequences were aligned to GRCh37/hg19 and variant calls were generated using CASAVA and Pindel. After removal of common single-nucleotide polymorphisms (SNP), intergenic and 3 0 /5 0 UTR variants, nonsplice-related intronic variants, and synonymous variants, the remaining variants were filtered for de novo dominant and homozygous and compound heterozygous recessive inheritance models. Except for the variants in PMPCB, no other pathogenic or likely pathogenic variants were identified in the family. Family C Trio-based WES was performed using previously published methods. 22, 23 In brief, genome partitioning was performed with SureSelect Human All Exon V5 (for affected individual) or V6 (for parents) (Agilent Technologies). The prepared libraries were run on HiSeq 2000/2500 (Illumina). Sequences were aligned to GRCh37/hg19 by NovoAlign. After PCR duplication by Picard Tools, variant calling and annotation were performed by Genome Analysis Toolkit and ANNOVAR. 24 The candidate variants were highlighted based on autosomal-or X-linked-dominant (de novo) and autosomal-recessive inheritance models. The candidate variants were validated by trio-based Sanger sequencing. Family D WES was performed for individual D:II-1 and her parents as reported previously 25 and the affected brother (D:II-2) separately. WES was performed at Wellcome Trust Sanger Institute (Hinxton, Cambridgeshire) as part of the EuroEPINOMICS RES project using the Illumina TruSeq DNA Sample Preparation Kit, the Agilent Technologies SureSelect Human All Exon 50Mb Kit, and the Illumina HiSeq2000 as per manufacturer's protocols. Sequencing of individual D:II-2 was performed at the University of Kiel using the TruSeq DNA Sample Preparation Kit and the Illumina HiSeq2000. Sequencing reads of all samples passing quality filtering were aligned to the GRCh37/hg19 human reference genome with the Burrows-Wheeler Aligner, marking of duplicate reads was performed using Picard. Variant calling was performed using the GATK 3.7 Haplotype caller, annotation of VCF files was performed using ANNOVAR. 24 Custom tools were used for the identification of potentially causative variants under various inheritance models. Other than the homozygous PMPCB variant in both siblings, no further candidates were identified under various inheritance models. The PMPCB variant was confirmed using Sanger sequencing.
Structural Modeling
The PMPCB variants identified in the affected individuals were modeled into the crystal structure of yeast MPP in complex with the cytochrome C oxidase IV presequence peptide 11 (PDB: 1hr8).
Mutations were introduced in silico and side chains positioned in preferred rotamer conformations while minimizing steric overlaps and optimizing hydrogen-bonding capabilities using the software Coot. 26 Images were made using The PyMOL Molecular Graphics System, v1. hESCs were cultured under the same conditions. Enzyme-free colony expansion using EDTA was performed every 3-4 days at a 1:6 ratio based on a protocol previously described. 30 For confirming the pluripotent status, immunocytochemical (ICC) staining for pluripotency markers 31 and PluriTest 32 was performed. Cells were seeded as single cells on 96-well plates (1 3 10 4 cells/well) and after 48 hr fixed for 15 min with 4% paraformaldehyde and incubated in blocking buffer (5% FCS, 95% 13 PBS, 0.3% Triton X-100) for 1 hr. Samples were incubated in primary antibody dilution (see Table S1 for details) overnight at 4 C. Cells were washed with 13 PBS, incubated with 1:1,000 diluted AlexaFluor 488 secondary antibody (Thermo Fisher Scientific) in blocking buffer for 2 hr at room temperature, and washed and images were obtained using an Opera imaging device (PerkinElmer).
Additionally, pellets with 1-1.5 3 10 6 cells were harvested and snap frozen in liquid nitrogen for PluriTest analysis. Samples were processed at AROS Applied Biotechnology A/S (Denmark) for RNA isolation and analyzed with Illumina HT-12 v4 microarrays following the manufacturer's instructions (Illumina). Raw data files were processed as previously described. 32 
Staining and Quantitative Imaging
Standard staining immunofluorescence protocols were applied. In short, cells were washed with PBS and permeabilized for 10 min in PBS-T (0.25% Triton X-100) followed by blocking in PBS with antibody-specific serum (5%) or 1% BSA for 30 min. Primary antibodies (see Table S1 for details) were diluted in blocking solution and secondary antibodies were diluted 1,000-fold and incubated for 2 hr at room temperature in the dark. After washing, nuclei were stained with Hoechst 33258 (Sigma, H6024; 0.1 mg/mL in PBS) for 20 min and washed again with PBS. The ready stained plates were covered with aluminum foil and stored at 4 C in the dark until image acquisition. Imaging was performed on the confocal Opera HCS Reader (PerkinElmer), 203 objective, Laser lines (405, 488 nm). Laser power and excitation time was adjusted for each staining separately to avoid detector saturation and to allow signal detection in the linear range. The filter and camera settings were optimized using PerkinElmer filter selection tool to avoid cross talk between channels. For each well, six images were taken at fixed positions for unbiased imaging. Images were stored for each Channel as flex files and finally imported in the Columbus-Data Base and Image analysis Software (PerkinElmer).
Yeast Strains and Growth Conditions
The Saccharomyces cerevisiae strains used in this study are derived from YPH499 (MATa, ade2-101, his3-D200, leu2-D1, ura3-52, trp1-D63, lys2-801). Mas1 mutant strains were generated by plasmid shuffling: YPH499 was transformed with a Yep352 plasmid encoding Mas1 under control of the MET25 promoter and CYC1 terminator. The chromosomal gene MAS1 was disrupted using a his3 cassette. The resulting strain was transformed with the pFL39 plasmid encoding Mas1 under its endogenous promoter and terminator region, in which the mutations had been introduced using site-directed mutagenesis. Cells were selected for plasmid loss by growth on medium supplemented with 5-fluoroorotic acid (5-FOA). The following strains were used for analysis: Mas1 (#4944; #5103), Mas1 Arg144Cys (#4945),
Arg144His (#5104) (these strains expressed Mas1 with an additional C-terminal HA tag), and Mas1 (#5101) and Mas1 Val146Gly (#5102). 
Isolation of Mitochondria from Yeast and hPSC
Yeast strains were grown on non-fermentable medium at 23 C or shifted for 10 hr to 37 C prior to isolation of mitochondria. Cells were harvested in logarithmic growth phase (OD 600 0.8-1.0) and mitochondria were isolated by differential centrifugation. 36 Aliquots were snap-frozen in liquid nitrogen and stored in SEM buffer (250 mM sucrose, 1 mM EDTA, 10 mM MOPS-KOH [pH 7.2]) at À80 C. hPSC, NES, and HDF were washed with PBS and incubated in solution A (20 mM HEPES-KOH [pH 7.6], 220 mM mannitol, 70 mM sucrose, 1 mM EDTA, 0.5 mM PMSF, 2 mg/mL BSA) for 15 min on ice. Subsequently cells were homogenized by 30 strokes using a glass potter. Samples were centrifuged at 800 3 g for 5 min at 4 C to remove unbroken cells and cellular debris.
The supernatant was subjected to centrifugation at 7,000 3 g for 15 min at 4 C. The obtained mitochondrial pellet was resuspended in solution B (solution A without BSA) and the protein concentration adjusted to 10 mg/mL with sucrose buffer (10 mM HEPES-KOH [pH 7.6], 0.5 M sucrose). Aliquots were stored at À80 C. Protein levels were analyzed by SDS-PAGE and western blotting according to standard protocols using the antibodies listed in Table S1 .
In Organello Import of Radiolabeled Precursor Proteins
Radiolabeled precursor proteins were synthesized in vitro using the rabbit reticulocyte lysate system (Promega) in the presence of C. Alternatively, mitochondria were subjected to an in organello heat shock (15 min 37 C) prior to addition of precursor, followed by import at 37 C. The membrane potential was disrupted by addition of AVO (8 mM antimycin A, 1 mM valinomycin, 20 mM oligomycin). Samples were treated with 50 mg/mL Proteinase K (Prot. K) for 10 min on ice to digest non-imported precursor proteins. Mitochondria were re-isolated by centrifugation at 16,000 3 g for 10 min at 4 C and washed with SEM buffer.
Samples were analyzed via SDS-PAGE and autoradiography.
In Vitro Processing
Isolated mitochondria (40 mg) were solubilized in reaction buffer (10 mM HEPES-KOH [pH 7.5], 1 mM MnCl 2 , 1 mM DTT) containing 0.5% digitonin, incubated for 15 min on ice, and centrifuged at 10,000 3 g for 10 min at 4 C. Obtained supernatant was incubated with radiolabeled frataxin (FXN) precursor for various time points at 37 C and analyzed by SDS-PAGE followed by western blotting and autoradiography. 37 Blue-Native PAGE
Respiratory chain complexes were analyzed by Blue-native polyacrylamide gel electrophoresis. Mitochondria (50 mg) were solubilized in digitonin buffer (1% (w/v) digitonin, 20 mM TrisHCl [pH 7.4], 0.5 mM EDTA, 10% (v/v) glycerol, 50 mM NaCl) and incubated on ice for 15 min. Samples were centrifuged at 20,000 3 g for 5 min at 4 C and the supernatant was loaded on a 4%-13% gradient BN-PAGE followed by western blotting.
Membrane Potential Measurement
The membrane potential (Dc) of mitochondria was assessed by fluorescence quenching using the potential-sensitive fluorescent dye 3,3 0 -dipropylthiadicarbocyanine iodide. Isolated mitochondria (50 mg) were incubated in membrane potential buffer (0. 
Human Tissue Biopsy Studies
Respiratory chain enzyme activities in muscle tissue were measured spectrophotometrically in post-600 g supernatants of individual A:II-1 and compared to a range determined from more than 20 control biopsies as described. 39 Blue native PAGE with in-gel activity staining for respiratory chain complexes I, II, IV, and V was performed on isolated membrane fractions obtained from tissues as described. 39, 40 The assembly of respiratory chain complex I was analyzed in isolated mitochondrial membrane fractions from individual A:II-1 fibroblasts using BN-PAGE and by western blotting using an antibody against NDUFS2, a component of the earliest assembly intermediates. 41, 42 Total aconitase activity in fibroblasts and muscle homogenates was measured spectrophotometrically. 43 The mitochondrial and cytoplasmic aconitase enzymes were separated on a gel and the activities measured individually using an in-gel activity stain as described. 44, 45 The relative proportion of the activities from mitochondrial and cytosolic aconitase was distributed over the total activity as measured spectrophotometrically to provide the activity of each enzyme separately. The assay has a coefficient of variation of <7% for each fraction. Protein steady-state levels were assayed by SDS-PAGE and western blotting. Lipoylation of the E2 components of pyruvate dehydrogenase and a-ketoglutarate dehydrogenase was evaluated using an anti-lipoid acid antibody. 45 All antibodies used are listed in Table S1 .
Results
Clinical Report
We identified five affected individuals from four unrelated families ( Figure 1A is summarized below and in Table 1 and is presented in detail in the Supplemental Note. All affected individuals presented with significant developmental regression or stagnation within the first 2 years of life, which followed a minor illness or vaccination in three children. Common neurological features included truncal hypotonia, lack of independent ambulation, and lack of speech. Seizures were observed in four of the five children with onset between 11 months and 24 months, including generalized tonicclonic seizures in the setting of fever, epileptic spasms, tonic seizures, and focal dyscognitive seizures. Features reported in a subset of affected individuals include ataxia, dystonia, acquired microcephaly, and spastic quadriplegia. Three affected individuals demonstrated clinical deterioration and early death before age 6 years. Brain MRI revealed T2 hyperintensities of the basal ganglia in all affected individuals ( Figure 1B ). Other observed brain MRI abnormalities included cerebral and cerebellar atrophy, which was demonstrated to be progressive in three individuals. Metabolic testing revealed elevated serum lactate in three, mild to borderline elevated serum pyruvate in two, and mildly elevated serum alanine in three of the five individuals. As all four PMPCB variants identified in the affected individuals affect amino acid residues that are highly conserved (Figure S1 ), the crystal structure of yeast MPP 11 was used to assess potential effects of the mutations (Figures 1C and S2) . The side chain of Arg144 is engaged in several hydrogen bonds that stabilize the protein fold, which the mutated residues (histidine and cysteine) cannot maintain ( Figure S2A ). Val146 is surface exposed and in proximity to the active site region ( Figure S2B ). Thr170 is located at the C-terminal end of an a helix and mutation to proline terminates the helix earlier ( Figure S2C ). Ile398 contributes to the packing of an a helix to a b sheet and lies close to the Mas1/Mas2 dimer interface. Mutation to a threonine results in a decreased side chain volume, hence altered packing and might impact on the heterodimer interaction ( Figure S2D ). Taken together, while the mutations do not directly affect the catalytic activity, they potentially result in changes of the stability of the protein's fold, accessibility of the active site, or dimer formation. In parallel, control hESC (C1) and hiPSC lines (C2.2, C2.5) were obtained or generated from healthy individuals who had no variants in PMPCB. We confirmed pluripotency by immunocytochemical marker staining and PluriTest 32 analysis (Figures 2A, S3A , and S3B) in all hESC and hiPSC cell lines. All hiPSC cell lines were furthermore tested for karyotypic stability with G-banding ( Figures  S3C-S3E ). In addition, to enable experimental analysis of cells that resemble the tissue predominantly affected in the PMPCB individuals, we differentiated both control and PMPCB hiPSCs toward neuroepithelial stem cells (NES). 33, 35 Differentiation was confirmed by immunocytochemical staining ( Figures S4A and S5 ). Control and affected individual hiPSCs and NES cells were expanded and mitochondria isolated. The protein steady-state levels of PMPCB were analyzed by SDS-PAGE and western blotting and revealed a decrease in PMPCB levels in all three affected individual hiPSC and NES lines ( Figures 2B, 2C, S4B, and S4C) . Furthermore, PMPCB displayed a change in migration behavior in mitochondria isolated from cells derived from the affected individual as it shifted to a slightly higher molecular weight. Protein levels of PMPCA, which together with PMPCB forms the active MPP heterodimer, were only mildly affected. We analyzed additional mitochondrial proteins that are substrates of MPP (FXN, NDUFA9, GRP75, Rieske). While the protein levels of NDUFA9, GRP75, and Rieske were unchanged in control and affected individual mitochondria, analysis of frataxin (FXN) demonstrated a strong increase in its intermediate form and a reduction of the mature Figure 2E ). 37 MPP processed FXN efficiently to its intermediate and mature form in the control mitochondria. PMPCB mutant mitochondria also demonstrated efficient precursor processing; however, iFXN accumulated and processing to the mature form was severely hampered. Therefore, the homozygous c.1265T>C (p.Ile422Thr) PMPCB variant results in an incomplete maturation of the FXN protein in vivo and in vitro.
Molecular Results and Structural Modeling
The observation of an in vivo MPP processing defect only for frataxin was surprising as the accumulation of iFXN and the lower amount of mature FXN pointed toward a strong decrease in MPP activity in the affected individual samples. FXN is involved in the biogenesis of Fe-S clusters in the mitochondrial matrix. This biosynthetic pathway is essential as critical cellular mechanisms such as nuclear DNA repair enzymes are dependent on Fe-S clusters. [48] [49] [50] iFXN plays a physiological role in Fe-S-cluster biogenesis as it can transfer Fe 2þ and Fe 3þ to the ISCU/NFS1/ISD11 iron-sulfur assembly complex. 51, 52 In comparison to iFXN, mature FXN binds iron more labile and does not interact as strongly with the ISCU/NFS1/ISD11 complex. It has therefore been proposed that an increase in iFXN protein level provides a mechanism for the cell to increase the rate of Fe-S-cluster biogenesis in times of higher demands such as during cell growth or mitochondrial biogenesis. Mature frataxin (mFXN) is predominant under steady-state conditions in non-dividing cells as it has a lower Fe-S-cluster biogenesis rate. 51 hPSCs are usually cultured in high-glucose medium and do not use mitochondria for oxidative phosphorylation. 30, 53 However, the role of mitochondria in the biosynthesis of Fe-S clusters remains essential in hPSCs even in the absence of respiration. We examined how the increased iFXN affected Fe-S-cluster biogenesis by analyzing the capacity of acquiring sulfur in hPSC and NES lines. The ISD complex represents an intermediate assembly during Fe-S-cluster biogenesis formed by NFS1 and ISD11 that detach sulfur from cysteine and transfer it to the ISCU protein. 38 FXN is an allosteric activator of this step. Formation of the ISD complex was strongly increased in hPSC and NES mitochondria of the affected individual D:II-2 with the homozygous c.1265T>C (p.Ile422Thr) PMPCB variant ( Figures 2F, S4D , and S4E). Together with the increased iFXN level, this indicates an enhanced Fe-S-cluster biogenesis in the PMPCB mutant mitochondria from hPSCs. Given the limitations of studying mitochondrial respiratory chain function in hPSCs due to their glycolytic metabolism and mitochondrial immaturity, we wanted to assess the effect of mutated PMPCB in a model organism that would allow for a switch between glycolytic and respiratory cell growth upon increased mitochondrial biogenesis and full functional activity.
PMPCB Mutations Impair Presequence Processing by MPP
The human PMPCB and the yeast homologous Mas1 are highly conserved and all PMPCB variants result in amino acid changes at conserved positions ( Figure S1 ). Therefore, we used the yeast Saccharomyces cerevisiae, in which mitochondrial protein biogenesis has been analyzed in detail, to model the identified PMPCB mutations. Figures 3A and S6A) . Notably, this impaired cell growth is observed under respiratory (glycerol as carbon source) but also fermentative (glucose as carbon source) conditions indicating that the mutations affect essential mitochondrial functions.
To explore whether impaired cell growth upon heat shock is due to loss of enzymatic MPP activity in the mutant Mas1 cells, MPP function was directly assessed by in organello import experiments of radiolabeled precursor proteins into mitochondria isolated from cells grown at 23 C. When the import experiments were performed at low temperature, MPP processing activity was comparable in wild-type and mutant Mas1 mitochondria ( Figure S6B and S6C). However, following a 15 min in organello heat shock prior to the import reaction ( Figures 3B and S6D) , a severe decrease in MPP processing activity in the mutant mitochondria was noted reflected in the accumulation of non-processed precursor proteins (Atp2, Sod2, Mdh1) inside mitochondria. Overall import competence was not affected as demonstrated by import of Hsp10, which uses the same protein import pathways but is not cleaved by MPP ( Figure 3B ). 37 Therefore, presequence processing activity of mutant MPP is severely hampered under heat stress. As MPP is the major presequence processing protease in mitochondria, we assessed the consequences of MPP inactivation in vivo by applying a heat shock to yeast cell cultures prior to isolation of mitochondria and testing an array of proteins which are imported via the presequence import pathway by immunoblotting (Figures 3C and S6E) . 6, 8, 55 Reflecting a severely impaired MPP function, compared to wild-type mitochondria, every presequence-targeted protein tested showed a significant accumulation of the immature precursor, and many also showed a decreased level of the fully processed, mature form. The affected proteins carry out various mitochondrial functions including reactive oxygen detoxification (Sod2), protein biogenesis and folding (Mdj1, Mge1, Hsp60), oxidative phosphorylation (Cox4, Cox6, Rip1, Atp2, Atp3), the citric acid cycle (Mdh1), and Fe-S-cluster biogenesis (Jac1). The mutations in Mas1 when challenged at 37 C affect processing of all incoming precursor proteins that possess presequences. Also, the Mas1 protein accumulated immature species, as it is processed by MPP upon import. Mutant Mas1 furthermore showed the same aberrant migration behavior as the homologous PMPCB mutant for p.Ile422Thr (compare western blot analysis of Mas1 in Figures 3C and S6E with PMPCB in Figures 2B and S4B) . Control proteins, which are not substrates of MPP, were not affected and showed similar levels in wild-type and mutant mitochondria (Figures 3C , right panel and S6E, Msp1). Taken together, the homologous mutations of the affected individuals A:II-1, B:II-2, and C:II-1 introduce a temperature-sensitive phenotype in the yeast Mas1 protein that leads to a loss of MPP function upon in organello or in vivo heat stress.
Mas1 Mutations Impact on the Essential Biogenesis of Fe-S Clusters
We hypothesized that yeast grown at permissive temperature (23 C) or exposed to heat stress could be an ideal tool to investigate the impact of the affected individuals' mutations on mitochondrial function. We speculated that yeast growth at 23 C may mimic cells from the affected individuals under resting steady-state conditions. Growth during heat stress may represent a model for cells of these individuals upon enhanced mitochondrial biogenesis, increased requirements of mitochondrial functions during growth and development, or cellular stress in the setting of fever or infection. Most components of the respiratory chain complexes are imported via the presequence import pathway and consequently have to undergo presequence processing by MPP. 8, 55, 56 We analyzed the integrity of the respiratory chain complexes in mitochondria isolated from cells after growth at permissive temperature or after heat shock to impair MPP activity using blue native PAGE which resolves the native, intact complexes after solubilization with mild non-ionic detergents. 57 In yeast, complexes III and IV form supercomplexes containing two units of complex III and one or two units of complex IV. 58 Immunoblotting revealed no changes in respiratory chain complexes in mitochondria isolated after growth at permissive temperature ( Figures 4A and S7A) . Upon heat shock, a mild reduction of both supercomplexes (III 2 IV 2 and III 2 IV) in the mutant mitochondria was detected ( Figures  4B and S7B ). The same was observed for complex II, while the ATP synthase (dimer and monomer of complex V) was not affected (Figures 4B and S7B) . Next, we measured the membrane potential Dc across the inner membrane, which depends on highly functional mitochondria and can therefore be used as a marker for the fitness of these organelles. Three of the four Mas1 mutations led to a slight but significant reduction of Dc when mitochondria were isolated after growth at elevated temperature ( Figures  4C and S7C) . The biogenesis of Fe-S clusters represents the only essential mitochondrial function, making these organelles indispensable for life under any growth condition. Since frataxin, which showed processing defects in affected individual hPSCs and fibroblasts, is involved in iron-sulfur cluster biogenesis, we assessed the formation of the ISD complex ( Figure S7D ). While the complex was formed in the Mas1 mutants comparably to wild-type upon growth at permissive temperature, complex formation was severely reduced upon inactivation of MPP by exposing the cell cultures to heat stress ( Figures 4D and S7E) . Thus early steps in the iron-sulfur cluster biosynthesis are clearly impaired.
Affected Individual Tissues Show Dysfunction of Iron-Sulfur Cluster Containing Enzymes
To study the functional impact of the PMPCB mutations in the affected individuals, several cellular functions Arg144Cys , and Mas1 Thr170Pro mutant mitochondria isolated after in vivo heat shock.
were reviewed in tissues from individual A:II-1. While enzyme activities of the respiratory chain were normal in fibroblasts and liver, complex II activity was significantly reduced in muscle ( Table 2) . Analysis of respiratory chain complexes using blue native PAGE with in-gel activity staining confirmed the severely decreased complex II activity in the A:II-1 muscle biopsy ( Figure 5A ) and protein steady-state analysis on SDS-PAGE also revealed mildly reduced levels of respiratory chain subunits ( Figure S8A ). Furthermore, blue native PAGE analysis of mitochondrial membrane fractions from A:II-1 fibroblasts followed by western blotting identified accumulation of several subassemblies of complex I at 100, 230, 400, 460, and 830 kDa, whereas in the assay control and all previously analyzed ten control fibroblasts only the fully assembled holocomplex at 1 MDa and a small amount at 230 kDa were visible ( Figure 5B) . 41 This shows an impact on complex I assembly, even though the amount of holocomplex was comparable to control mitochondria such that enzyme function was preserved.
As the respiratory chain complexes I, II, and III contain several ironsulfur clusters, and Mas1 mutations severely decreased cluster biogenesis, other Fe-S-cluster-dependent enzymes such as lipoic acid synthetase (LIAS) involved in lipoylation of mitochondrial proteins and aconitase were evaluated. The protein steady-state levels of lipoylated E2 subunits of pyruvate dehydrogenase and a-ketoglutarate dehydrogenase were normal in fibroblasts and muscle of individual A:II-1 revealing normal functional activity of LIAS ( Figure S8B ). While the mitochondrial and cytosolic aconitase activity of affected individual fibroblasts was comparable to control ( Figure 5C ), the enzymatic activity of both enzymes was deficient in muscle tissue of individual A:II-1 ( Figure 5D ), even though the protein levels of both aconitase enzymes remained normal ( Figure S8C ), likely because the defect affected the Fe-S cofactor rather than the apoenzyme. Thus, several iron-sulfur cluster containing mitochondrial and cytosolic enzymes are affected and this defect is more pronounced in muscle tissue than in fibroblasts. In all tissues analyzed, normal amounts of mature citrate synthase, which has an MPP cleavable leader sequence, were detected ( Figure S8C ), illustrating that in this relatively less severely affected individual, the impact on cellular bioenergetics is not a generalizable effect on protein processing but specific to iron-sulfur cluster biogenesis.
Discussion
In this study, we identify four families with biallelic pathogenic variants in PMPCB, encoding the catalytic subunit of MPP. The phenotypic features in all affected individuals include a combination of Leigh-like features of episodic regression and basal ganglia lesions, often in the setting of febrile illnesses, but also with prominent cerebellar atrophy and increased T2 signal of the cerebellar cortex (families A and B). The more severely affected individuals also had therapy-resistant epileptic encephalopathy (family D) or leukodystrophy (family C). The phenotype is similar to that reported in individuals with mutations in the non-catalytic MPP subunit PMPCA (MIM: 613036) of cerebellar ataxia 59, 60 and early-onset mitochondrial encephalopathy. 61 The disorders secondary to mutations in PMPCA and PMPCB can jointly be considered disorders of MPP function. However, most of the reported PMPCA individuals have achieved independent ambulation and verbal language, which is a milder manifestation compared to the PMPCB phenotype. In the PMPCA individuals, the severity of disease seemed to depend on the mutation's vicinity to the glycine-rich loop of PMPCA, which has been implicated in substrate recognition and binding. 13 The more severe phenotype seen in the PMPCB individuals may be due to a stronger impact on MPP activity by mutations in the catalytic PMPCB subunit, suggesting a correlation of the variability of the phenotype and the degree of MPP dysfunction. Third, cells that are mostly fermentative and have low mitochondrial demands such as stem cells or fibroblasts are less affected than primarily aerobic muscle tissue or neurons. It is tempting to speculate that under resting conditions PMPCB mutations can still maintain the basic functional requirements of mitochondria, which is also reflected in the hPSC/NES PMPCB lines. However, upon increased need for mitochondrial biogenesis during early childhood growth and development, or upon cellular stress in the setting of infection or fever, mitochondria with mutated PMPCB are insufficiently capable of adjusting to the increasing demands on precursor processing, hampering mitochondrial biogenesis, and resulting in neurological injury.
In vivo and in vitro analysis of PMPCB hPSCs, NES, and fibroblast mitochondria revealed a strong accumulation of iFXN and a block of its second MPP processing step. FXN is an unusual substrate as it undergoes two-step processing by MPP 46, 47 and this sequential processing might render FXN especially sensitive toward MPP dysfunction. We hypothesize that the sequential processing of FXN might serve as a safety loop to ensure maintenance of Fe-S-cluster biosynthesis under stressed conditions or upon increased mitochondrial biogenesis in which an elevated protein import rate saturates the processing capacity of MPP. The two-step processing of FXN would then enable adaptation of FXN activity and thereby Fe-S-cluster biogenesis upon changes in cellular conditions. 51 The second $protein À1 and the ratio of the activity over citrate synthase is shown. b The distribution of the results from controls (n ¼ 25) when log transformed is normal, and the affected individual value expressed as a Z-score of this control range. A SD of < À2 is considered significant. NA, not applicable.
FXN processing has also been described as less efficient than the generation of FXN intermediates. 46 This might explain why only decreased mFXN protein levels have been detected in samples obtained of the affected individuals, while processing defects in other (one-step) MPP substrates were not yet observed. The FXN protein itself has been studied extensively as loss of function causes the autosomal-recessive degenerative disease Friedreich ataxia (FRDA). 62, 63 However, FRDA samples revealed a depletion of all FXN isoforms. 51, 64 In contrast, mutations in PMPCB showed only a decrease in mFXN protein levels, while iFXN was even increased. Our results suggest that biogenesis of Fe-S clusters is affected early upon MPP dysfunction and may represent the primary pathophysiologic mechanism triggered by mutations in the catalytic MPP subunit and its sensitive impact on FXN processing. Similar to mutations in ironsulfur-cluster biogenesis defects, such as NFU1, BOLA3, NFS1, IBA57, or ISCU, [65] [66] [67] [68] [69] [70] [71] mutations in PMPCB impact the function of several iron-sulfur-cluster-containing enzymes particularly in muscle, the most affected tissue included in our analysis. Respiratory chain complex II is sensitive to iron-sulfur cluster dysfunction [65] [66] [67] [68] [69] [70] [71] and its enzymatic activity was virtually absent in the affected individual muscle biopsy. Assembly of complex I, which contains eight iron-sulfur clusters, 72 was hampered in fibroblast mitochondria leading to the accumulation of abnormal subcomplexes. In contrast to genetic defects in enzymes directly involved in Fe-S-cluster biogenesis, [65] [66] [67] [68] [69] [70] [71] but similar to frataxin deficiency, 73 there was normal lipoylation and activity of mitochondrial lipoate-bearing enzymes, indicating that lipoic acid synthetase (LIAS) activity, which depends on an Fe-S cluster, was still sufficiently preserved, likely explaining why the phenotype is less severe than seen in iron-sulfur-cluster biogenesis disorders such as NFU1. The enzymatic activity of both mitochondrial and cytosolic aconitase was severely decreased in muscle tissue. Aconitase activity was still preserved in cultured fibroblasts, which is a more glycolytic cell type than muscle and might therefore be less affected by the PMPCB mutations. After their synthesis in mitochondria, Fe-S clusters are exported from the organelle as they are essential for the enzymatic function of several nuclear and cytosolic proteins, including a pivotal role in DNA synthesis and repair, chromosome segregation, or protein translation processes. The decrease of the cytosolic aconitase activity indicates that the defects in Fe-S-cluster biogenesis triggered by mutations in PMPCB can affect mitochondrial bioenergetics and in addition cellular functions outside of the mitochondrial organelle, which also explains the growth defects of Mas1 mutant yeast under fermentative conditions. The data on Fe-S-cluster biosynthesis in our PMPCB hPSC and NES lines differed from the results obtained in affected individuals' tissues, fibroblasts, and yeast. While Fe-S-cluster biosynthesis is an essential pathway in hPSC and NES lines, these models may have limitations when assessing the impact of PMPCB impairment on Fe-S-cluster biosynthesis under oxidative growth or stress conditions. While the increased iFXN levels and enhanced ISD complex formation suggested an elevation of Fe-S-cluster biogenesis in hPSC and NES PMPCB mitochondria, this biosynthesis pathway was decreasing early upon MPP inactivation in yeast mitochondria bearing the homologous Mas1 mutations. However, it is tempting to hypothesize that the increased ISD complex formation in hPSCs and NES is caused by the increased iFXN levels providing the cell with a mechanism to adapt Fe-S-cluster biogenesis to changes in cellular demands. Furthermore, our hPSC data and also analysis of the PMPCA individuals identified frataxin as an early marker for MPP dysfunction as it is the only MPP substrate identified to be affected in the PMPCB individuals in vivo. Employing our yeast model, we could show that MPP dysfunction caused by the Mas1 mutations affects all presequence-possessing precursors. Therefore, we hypothesize that all mitochondrial functions will be ultimately affected by the mutations in PMPCB if conditions are severe enough and that the FXN levels and the data obtained in yeast point toward an early impact on Fe-S-cluster biogenesis. The stringent in vivo conditions that allow precise induction of MPP dysfunction in yeast underline the importance of unicellular model organism like S. cerevisiae to mimic and decipher pathogenic mechanisms that result in complex human diseases.
In summary, we identify PMPCB mutations in a mitochondrial disease resulting in Leigh-like neurodegeneration in childhood with prominent cerebellar atrophy. With the identification of biallelic pathogenic variants in PMPCB, we establish dysfunction of the catalytic subunit of the mitochondrial presequence processing protease as the disease mechanism accompanied by changes in ironsulfur-cluster biogenesis.
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